The global flow cytometry market size was valued at USD 5.3 billion in 2023, driven by the advent of artificial intelligence enabled automated systems across the globe. The market is expected to grow at a CAGR of 7.8% during the forecast period of 2024-2032, with the values likely to rise from USD 5.7 billion in 2024 to USD 10.4 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Flow cytometry is an analytical technique used to identify cells based on molecular characteristics. It is used to isolate information on specific types from different organs of the body or bodily fluids which may be difficult to separate from each other. It is widely used by researchers in immunophenotyping, cell cycle analysis, cell sorting, apoptosis, and intracellular calcium flux.
There has been significant improvement in the flow cytometer technologies, with a vision to offer improved workflows via innovation and automation. The market is driven by increasing mergers and collaborations between companies and advancements in the existing technologies for better solutions. The advent of artificial intelligence and robotics is a major driver for enhanced market value. The key drivers responsible for the increasing flow cytometry market demand are as follows:
With increasing advancements in technology, the flow cytometer design has constantly improved to give improved visual data in lesser time span. Software guided tools have helped in enhancing the usability. In addition, the devices have seen significant size reduction, making them compact and easier to maintain. Such developments are anticipated to make the solutions more accessible in the forecast period.
Conventionally, the flow cytometry performance has been dependent on fluorophore excitation. However, recent advancements have given rise to laser technology aided flow cytometry. Choosing a laser over other sources enables the researchers to make informed decisions by offering better spectral width, intensity, and stability. Laser diode modules like Power Technology’s IQ and CK are some of the most recent products to have emerged in the market.
The flow cytometry market value is fueled by increasing integration of robotic and artificial intelligence enabled technologies into the healthcare research ecosystem. In June 2023, BD launched an automated instrument to prepare samples for clinical diagnostics with the help of liquid-handling robotics. The BD FACSDuet™ Premium Sample Preparation System automates the sample preparation process (which includes cocktailing, washing, and centrifuging) and transfers it to the BD FACSLyric™ Clinical Flow Cytometry System without any human intervention. The rising trend of automation is expected to help the healthcare professionals focus on the analysis and interpretation of the samples and offer improved outcomes for the patients.
The market for flow cytometry is experiencing growth in investments with various companies coming in to adopt improved technologies and foster innovation. Zeiss Ventures entered the life sciences domain by making a USD 2.5 million investment in Zomp, a Cambridge based 3D imaging flow cytometer start-up. By facilitating image-based services, the company aims at delivering morphological as well as spatial information at a single cell level. This also indicates the growing application of imaging technologies in the clinical research domain.
Understanding the rising demand for flow cytometry techniques, prominent companies have made crucial efforts to enter the domain and foster innovation in the flow cytometry market landscape. In February 2023, Cytek™ Biosciences acquired DiaSorin’s completely owned flow cytometry and imaging unit Luminex Corporation. With this acquisition, Cytek will be able to provide a huge line-up of cell analysis solutions that combine high-resolution imagery with sensitivity, speed, and improved phenotyping abilities. The latest addition of Guava® flow cytometers is anticipated to bring cost effective and personal instruments alternatives, helping the expansion of research services.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product & Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End-use
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
With a robust healthcare infrastructure along with the presence of prominent MedTech players, North America, particularly the United States is projected to lead the flow cytometry market share. Europe is another player with continuous research advancements which can be attributed to the existence of impactful research and academic institutions in the region.
With a significant emphasis on improving the healthcare infrastructure, the Asia Pacific region is also emerging as a major market for flow cytometry. Japan is a significant region that holds substantial flow cytometry market share in the region. In May 2023, Sysmex Corporation announced the launch of their clinical Flow Cytometer XF-1600 in the country. It will also include the sample preparation system PS-10, antibody reagents, and other related products. The emphasis on bringing newer technologies in order to upgrade the existing ecosystem is a major contributor to the market growth.
In May 2023, FlowMetric (a KCAS company) announced their partnership with Cytek™ Biosciences to expand their product portfolio and offer premium laboratory services by developing a next generation flow cytometric instrumentation system. This partnership is expected to upgrade Cytek’s flow cytometry system ‘Cytek Aurora’ with the help of FlowMetric’s expertise to deliver high resolution data at the unicellular level.
Such strategic partnerships are expected to bolster the global flow cytometry market growth exponentially. Here are some of the key players of the market:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product & Services
|Breakup by Technology
|Breakup by Application
|Breakup by End-use
|Breakup by Region
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Flow Cytometry Market Overview
3.1 Global Flow Cytometry Market Historical Value (2017-2023)
3.2 Global Flow Cytometry Market Forecast Value (2024-2032)
4 Global Flow Cytometry Market Landscape
4.1 Global Flow Cytometry Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Flow Cytometry Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
4.2.4 Analysis by End-use
5 Global Flow Cytometry Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Flow Cytometry Market Segmentation
6.1 Global Flow Cytometry Market by Product & Services
6.1.1 Market Overview
220.127.116.11 Cell Analysers
18.104.22.168 Cell Sorters
6.1.3 Reagents & Consumables
6.2 Global Flow Cytometry Market by Technology
6.2.1 Market Overview
6.3 Global Flow Cytometry Market by Application
6.3.1 Market Overview
22.214.171.124 Pharmaceutical & Biotechnology
126.96.36.199.1 Drug Discovery
188.8.131.52.2 Stem Cell Research
184.108.40.206.3 In Vitro Toxicity Testing
220.127.116.11 Cell Sorting
18.104.22.168 Cell Cycle Analysis
22.214.171.124 Cell Viability
126.96.36.199 Cancer Diagnostics
188.8.131.52 Organ Transplantation
184.108.40.206 Autoimmune Diseases
6.4 Global Flow Cytometry Market by End-use
6.4.1 Market Overview
6.4.2 Commercial Organizations
6.4.3 Biotechnology Companies
6.4.4 Pharmaceutical Companies
6.4.7 Academic Institutes
6.4.8 Clinical Testing Labs
6.5 Global Flow Cytometry Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Flow Cytometry Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Flow Cytometry Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Flow Cytometry Market
9.1 Market Share by Country
10 Latin America Flow Cytometry Market
10.1 Market Share by Country
11 Middle East and Africa Flow Cytometry Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.2 US FDA
16.3 EU EMA
16.4 INDIA CDSCO
16.5 JAPAN PMDA
17 Supplier Landscape
17.1 Danaher Corp.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Becton, Dickinson, and Company (BD)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Beckman Coulter, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Sysmex Corp.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Agilent Technologies, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Apogee Flow Systems Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Bio-Rad Laboratories, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Stratedigm, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 DiaSorin SpA
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Miltenyi Biotec
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 Sony Biotechnology, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Merck KGaA
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Luminex Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.15 Nanocellect Biomedical
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions Certifications
18 Global Flow Cytometry Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 5.3 billion in 2023 driven by the application of robotics and artificial intelligence enabled automated systems across the globe.
The market is anticipated to grow at a CAGR of 7.8% during the forecast period of 2024-2032, likely to reach a market value of USD 10.4 billion by 2032.
The market demand is driven by rising application of flow cytometers in various research and clinical domains which include cell cycle analysis, cell sorting, apoptosis and immunophenotyping.
The major market trend involves around the increasing number of mergers and collaborations between influential companies to provide improved solutions. In February 2023, Cytek™ Biosciences acquired DiaSorin’s flow cytometry and imaging unit Luminex Corporation.
Based on product types, the market is divided into instruments, reagents and consumables, software, accessories, and services. Instruments are further divided into cell analysers and sorters.
Cell based, and bead based are common technologies available in the market.
Common application areas include industrial, research as well as clinical. Research is further segmented into pharmaceutical and biotechnology, cell sorting, cell cycle analysis, immunology, cell viability and others whereas clinical can be further broken down to cancer diagnostics, organ transplantation, autoimmune diseases, haematology, and others.
Major end users include commercial organizations, biotechnology companies, pharmaceutical companies, CROs, hospitals, academic institutes, and clinical testing labs.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Danaher Corp., Becton, Dickinson, and Company (BD), Sysmex Corp., Agilent Technologies, Inc., Apogee Flow Systems Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Stratedigm, Inc., DiaSorin SpA, Miltenyi Biotec, and Sony Biotechnology, Inc.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.